Sanofi India gains as quarterly profit doubles on strong diabetes business performance

Sanofi India

30/10/2026 05:43

** Shares in Sanofi India SANO.NS up as much as 7.3% at a three-month high of 3,422.60 rupees, last up nearly 2% 
** Company's September-quarter profit more than doubles to 1.17 billion rupees ($12.29 million), revenue from operations up 3.4%  
** Results backed by high single-digit growth in insulin portfolio, CEO says diabetes business is "firmly in momentum" 
** Stock down ~21 so far this year


($1 = 95.1900 Indian rupees)

 (Reporting by Prerna Bedi in Bengaluru)
 ((Prerna.Bedi@thomsonreuters.com; +91 98052 24616;))